|Exchange:||American Stock Exchange|
|PharmAthene, Inc., was incorporated under the laws of the State of Delaware as Healthcare Acquisition Corp. (HAQ) on April 25, 2005. On August 3, 2007, HAQ consummated a merger with PharmAthene, Inc. and changed its name from Healthcare Acquisition Corp. to PharmAthene, Inc. It is a biodefense company, which is engaged in the development and commercialization of medical countermeasures against biological and chemical weapons. Its biodefense portfolio includes the product candidates namely SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine; Valortim®, a fully human monoclonal antibody for the prevention and treatment of anthrax infection, and; rBChE (recombinant butyrylcholinesterase) bioscavanger, a medical countermeasure for nerve agent poisoning by organophosphorous compounds, including nerve gases and pesticides. The Company’s customers are the U.S. Department of Defense (the DoD), the National Institute of Allergy and Infectious Diseases (‘NIAID), the Biomedical Advanced Research and Development Authority (‘BARDA’), and the National Institute of Health (NIH). The Company is subject to various federal, state and local laws, regulations and recommendations relating to safe working conditions, laboratory and manufacturing practices, the experimental use of animals, and the use and disposal of hazardous or potentially hazardous substances, including radioactive compounds and infectious disease agents, used in connection with its various activities.|
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.